• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于提高老年中风幸存者药物依从性的移动健康应用程序:开发与可用性研究。

mHealth App to improve medication adherence among older adult stroke survivors: Development and usability study.

作者信息

Cao Wenjing, Wang Juan, Wang Yuhui, Hassan Intan Idiana, Kadir Azidah Abdul

机构信息

Xiangnan University, Chenzhou, Hunan Province, China.

School of Health Sciences, Universiti Sains Malaysia, Kota Baru, Kelantan, Malaysia.

出版信息

Digit Health. 2024 Mar 6;10:20552076241236291. doi: 10.1177/20552076241236291. eCollection 2024 Jan-Dec.

DOI:10.1177/20552076241236291
PMID:38465293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921861/
Abstract

BACKGROUND

Effective medication adherence is vital for older adult stroke survivors, yet 20-33% cease treatment within a year post-discharge, increasing risks of recurrent strokes and mortality. A mobile health (mHealth) app could be a novel tool to improve medication adherence among stroke survivors because of its potential to increase patient empowerment. A few stroke-related apps provide information and support to stroke survivors. However, none have focused on medication adherence and documented their development and evaluation process, particularly those focused on this older population.

OBJECTIVE

This study aims to design and develop a smartphone app called OASapp to improve medication adherence among older adult stroke survivors and evaluate its usability.

METHODS

OASapp was developed in a three-phase development process. Phase 1 is the exploration phase (including a cross-sectional survey, a systematic review, a search for stroke apps on the app stores of Apple App Store and Google Play Store, and a nominal group technique). In phase 2, a prototype was designed based on the Health Belief Model and Technology Acceptance Model. In phase 3, Alpha and Beta testing was conducted to validate the app.

RESULTS

Twenty-five features for inclusion in the app were collected in round one, and 14 features remained and were ranked by the participants during nominal group technique. OASapp included five core components (medication management, risk factor management, health information, communication, and stroke map). Users of OASapp were satisfied based on reports from Alpha and Beta testing. The mean Usability Metric for User Experience (UMUX) score was 71.4 points (SD 14.6 points).

CONCLUSION

OASapp was successfully developed using comprehensive, robust, and theory-based methods and was found to be highly accepted by users. Further research is needed to establish the clinical efficacy of the app so that it can be utilized to improve clinically relevant outcomes.

摘要

背景

有效的药物依从性对老年中风幸存者至关重要,但20%-33%的患者在出院后一年内停止治疗,这增加了中风复发和死亡的风险。移动健康(mHealth)应用程序可能是一种改善中风幸存者药物依从性的新工具,因为它有可能增强患者的自主权。一些与中风相关的应用程序为中风幸存者提供信息和支持。然而,没有一个专注于药物依从性,也没有记录其开发和评估过程,特别是那些针对老年人群体的应用程序。

目的

本研究旨在设计和开发一款名为OASapp的智能手机应用程序,以提高老年中风幸存者的药物依从性,并评估其可用性。

方法

OASapp是通过三个阶段的开发过程开发的。第一阶段是探索阶段(包括横断面调查、系统评价、在苹果应用商店和谷歌Play商店搜索中风应用程序,以及名义群体技术)。在第二阶段,基于健康信念模型和技术接受模型设计了一个原型。在第三阶段,进行了Alpha和Beta测试以验证该应用程序。

结果

在第一轮中收集了25个纳入该应用程序的功能,在名义群体技术过程中,参与者保留了14个功能并对其进行了排序。OASapp包括五个核心组件(药物管理、风险因素管理、健康信息、通信和中风地图)。根据Alpha和Beta测试的报告,OASapp的用户感到满意。用户体验可用性指标(UMUX)的平均得分为71.4分(标准差14.6分)。

结论

OASapp是使用全面、稳健且基于理论的方法成功开发的,并且被发现受到用户的高度接受。需要进一步研究以确定该应用程序的临床疗效,以便它可以用于改善临床相关结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/88f1160bd278/10.1177_20552076241236291-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/76e9cdd1c3e6/10.1177_20552076241236291-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/681c4c6c3a38/10.1177_20552076241236291-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/fc501cea9291/10.1177_20552076241236291-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/d63312b146d9/10.1177_20552076241236291-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/7527d60650ad/10.1177_20552076241236291-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/6379a8d49cc3/10.1177_20552076241236291-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/88f1160bd278/10.1177_20552076241236291-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/76e9cdd1c3e6/10.1177_20552076241236291-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/681c4c6c3a38/10.1177_20552076241236291-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/fc501cea9291/10.1177_20552076241236291-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/d63312b146d9/10.1177_20552076241236291-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/7527d60650ad/10.1177_20552076241236291-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/6379a8d49cc3/10.1177_20552076241236291-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ae/10921861/88f1160bd278/10.1177_20552076241236291-fig7.jpg

相似文献

1
mHealth App to improve medication adherence among older adult stroke survivors: Development and usability study.用于提高老年中风幸存者药物依从性的移动健康应用程序:开发与可用性研究。
Digit Health. 2024 Mar 6;10:20552076241236291. doi: 10.1177/20552076241236291. eCollection 2024 Jan-Dec.
2
Features of Cancer mHealth Apps and Evidence for Patient Preferences: Scoping Literature Review.癌症移动健康应用程序的特点及患者偏好证据:范围性文献综述
JMIR Cancer. 2023 Apr 28;9:e37330. doi: 10.2196/37330.
3
Mobile Apps for Medication Management: Review and Analysis.移动医疗应用程序在药物管理中的应用:综述与分析。
JMIR Mhealth Uhealth. 2019 Sep 11;7(9):e13608. doi: 10.2196/13608.
4
The Development of a Hypertension Prevention and Financial-Incentive mHealth Program Using a "No-Code" Mobile App Builder: Development and Usability Study.使用“无代码”移动应用构建器开发高血压预防与经济激励移动健康计划:开发与可用性研究
JMIR Form Res. 2023 Apr 5;7:e43823. doi: 10.2196/43823.
5
Tools for Evaluating the Content, Efficacy, and Usability of Mobile Health Apps According to the Consensus-Based Standards for the Selection of Health Measurement Instruments: Systematic Review.根据基于共识的健康测量仪器选择标准评估移动健康应用程序的内容、疗效和可用性的工具:系统评价。
JMIR Mhealth Uhealth. 2021 Dec 1;9(12):e15433. doi: 10.2196/15433.
6
Mobile App Prototype in Older Adults for Postfracture Acute Pain Management: User-Centered Design Approach.针对老年人骨折后急性疼痛管理的移动应用程序原型:以用户为中心的设计方法。
JMIR Aging. 2022 Oct 17;5(4):e37772. doi: 10.2196/37772.
7
Medication Adherence Apps: Review and Content Analysis.药物依从性应用程序:综述与内容分析
JMIR Mhealth Uhealth. 2018 Mar 16;6(3):e62. doi: 10.2196/mhealth.6432.
8
Usability and Utility of a Mobile App to Improve Medication Adherence Among Ambulatory Care Patients in Malaysia: Qualitative Study.马来西亚门诊患者使用移动应用程序提高用药依从性的可用性和实用性:定性研究。
JMIR Mhealth Uhealth. 2020 Jan 31;8(1):e15146. doi: 10.2196/15146.
9
Features, Design, and Adherence to Evidence-Based Behavioral Parenting Principles in Commercial mHealth Parenting Apps: Systematic Review.商业移动健康育儿应用程序的特点、设计及对循证行为育儿原则的遵循情况:系统评价
JMIR Pediatr Parent. 2023 Jun 1;6:e43626. doi: 10.2196/43626.
10
Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development.促进口服化疗依从性和症状管理的移动应用程序:设计与开发方案
JMIR Res Protoc. 2017 Apr 20;6(4):e62. doi: 10.2196/resprot.6198.

引用本文的文献

1
Facilitators, barriers, and recommendations for mobile health applications among Chinese older populations: a scoping review.中国老年人群体中移动健康应用的促进因素、障碍及建议:一项范围综述
BMC Geriatr. 2025 May 31;25(1):396. doi: 10.1186/s12877-025-06010-8.
2
Older adult stroke survivors' needs and perspectives of a stroke app: a qualitative study.老年中风幸存者对中风应用程序的需求和看法:一项定性研究。
BMC Geriatr. 2025 Mar 29;25(1):212. doi: 10.1186/s12877-025-05849-1.

本文引用的文献

1
Effectiveness of mobile application interventions for stroke survivors: systematic review and meta-analysis.移动应用程序干预对脑卒中幸存者的有效性:系统评价和荟萃分析。
BMC Med Inform Decis Mak. 2024 Jan 2;24(1):6. doi: 10.1186/s12911-023-02391-1.
2
Description of apps targeting stroke patients: A review of apps store.针对中风患者的应用程序描述:应用商店综述。
Digit Health. 2023 Jun 16;9:20552076231181473. doi: 10.1177/20552076231181473. eCollection 2023 Jan-Dec.
3
User-Centered Mobile Applications for Stroke Survivors (MAPPS): A Mixed-Methods Study of Patient Preferences.
以患者为中心的脑卒中幸存者移动应用(MAPPS):一项关于患者偏好的混合方法研究。
Arch Phys Med Rehabil. 2023 Oct;104(10):1573-1579. doi: 10.1016/j.apmr.2023.05.009. Epub 2023 Jun 8.
4
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis.药物不依从与主要可改变的卒中相关疾病对卒中预防和死亡率的影响:一项荟萃分析。
J Neurol. 2023 May;270(5):2504-2516. doi: 10.1007/s00415-023-11601-9. Epub 2023 Feb 27.
5
Medication non-adherence and associated factors among older adult stroke survivors in China.中国老年脑卒中幸存者的药物治疗不依从性及相关因素
Front Pharmacol. 2022 Nov 24;13:1054603. doi: 10.3389/fphar.2022.1054603. eCollection 2022.
6
Antithrombotics prescription and adherence among stroke survivors: A systematic review and meta-analysis.抗血栓药物处方和卒中幸存者的依从性:系统评价和荟萃分析。
Brain Behav. 2022 Oct;12(10):e2752. doi: 10.1002/brb3.2752. Epub 2022 Sep 6.
7
Using nominal group technique among resident physicians to identify key attributes of a burnout prevention program.运用名义群体技术在住院医师中确定预防职业倦怠计划的关键属性。
PLoS One. 2022 Mar 18;17(3):e0264921. doi: 10.1371/journal.pone.0264921. eCollection 2022.
8
Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.数字健康技术改善结核病患者的药物依从性和治疗结局:随机对照试验的系统评价。
J Med Internet Res. 2022 Feb 23;24(2):e33062. doi: 10.2196/33062.
9
Better Medications Adherence Lowers Cardiovascular Events, Stroke, and All-Cause Mortality Risk: A Dose-Response Meta-Analysis.更好的药物依从性可降低心血管事件、中风和全因死亡风险:一项剂量反应荟萃分析。
J Cardiovasc Dev Dis. 2021 Nov 2;8(11):146. doi: 10.3390/jcdd8110146.
10
Impact of mobile health and telehealth technology on medication adherence of stroke patients: a systematic review and meta-analysis of randomized controlled trials.移动医疗和远程医疗技术对脑卒中患者服药依从性的影响:一项随机对照试验的系统评价和荟萃分析。
Int J Clin Pharm. 2022 Feb;44(1):4-14. doi: 10.1007/s11096-021-01351-x. Epub 2021 Nov 20.